Form 4: Ameren Corp Director Catherine Brune Reports Stock Acquisition
SEC Form 4 Filing
Director Catherine Brune acquired 1,911 shares of Ameren Corp common stock as part of director compensation and dividend reinvestment.
Summary
- Catherine S. Brune, a director of Ameren Corp, reported a transaction on January 3, 2025.
- She acquired 1,911 shares of Ameren Corp common stock as director compensation.
- The price per share for this acquisition was $0.
- Following the transaction, Brune beneficially owns 26,012 shares of Ameren Corp.
- This amount includes 738 shares acquired through reinvested dividends during 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, which is neither particularly positive nor negative.
Positives
- The director's continued investment in the company through stock acquisitions signals confidence in Ameren Corp's future.
Future Outlook
There are no specific forward-looking statements in this document.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine insider transaction.
Key Dates
| Date | Description |
|---|---|
| 2024 | 738 shares acquired through reinvested dividends during the first through fourth quarters |
| 01/03/2025 | Date of transaction: Acquisition of 1,911 shares of Ameren Corp common stock as director compensation |
| 01/07/2025 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.